The HEPSANET score to assess treatment eligibility of chronic hepatitis B in Africa

被引：0

作者：

Wang, Jian ^{[1
,2
]}

Zhang, Shaoqiu ^{[1
]}

Jiang, Chao ^{[3
]}

Wu, Chao ^{[1
,2
]}

Huang, Rui ^{[1
,2
]}

机构：

[1] Nanjing Univ, Nanjing Drum Tower Hosp, Dept Infect Dis, Affiliated Hosp,Med Sch, Nanjing 210008, Jiangsu, Peoples R China

[2] Nanjing Univ, Inst Viruses & Infect Dis, Nanjing, Jiangsu, Peoples R China

[3] Jiangsu Univ, Dept Infect Dis, Clin Coll, Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China

来源：

LANCET GASTROENTEROLOGY & HEPATOLOGY | 2024年 / 9卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页数：2

共 50 条

[41] Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care center
Jachs, Mathias
Sauberer, Raphael
Stiegler, Alexander
Dechene, Anton
Tazreiter, Raphael
Hartl, Lukas
Bauer, David
Balcar, Lorenz
Strassl, Robert
Mandorfer, Mattias
Trauner, Michael
Munda, Petra
Ferenci, Peter
Reiberger, Thomas
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2023, 11 (03) : 293 - 304
[42] TREATMENT EVALUATION, TREATMENT ELIGIBILITY, AND ANTIVIRAL THERAPY AMONG ASIAN AND NON-ASIAN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
Huang, Daniel
Nguyen, Vy H.
Trinh, Huy N.
Ogawa, Eiichi
Enomoto, Masaru
Kozuka, Ritsuzo
Marciano, Sebastian
Suzuki, Takanori
Yoshimaru, Yoko
Ko, Kwan-Lung
Hui, Rex Wan-Hin
Lee, Dong Hyun
Go, Min Seok
Lee, Chul-Jin
Preda, Carmen Monica
Quek, Sabrina
Khine, Htet Htet Toe Wai
Takahashi, Hirokazu
Inoue, Kaori
Maeda, Mayumi
Hoang, Joseph
Kudaravalli, Sahith
Trinh, Lindsey
Chau, Angela
Li, Jiayi
Zhang, Jianqing
Wong, Christopher
Wong, Clifford
Cheung, Ramsey C.
Yuen, Man-Fung
Tanaka, Yasuhito
Gadano, Adrian
Lim, Seng Gee
Nguyen, Mindie H.
HEPATOLOGY, 2021, 74 : 467A - 468A
[43] Monitoring Gaps and Treatment Disparities Among Adults With Chronic Hepatitis B Infection in the United States: Role of Treatment Eligibility Criteria
Wong, Robert
Therapondos, George
Jain, Mamta K.
Niu, Bolin
Kshirsagar, Onkar
Thamer, Mae
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1216 - S1217
[44] Low eligibility for hepatitis B treatment in the Brazilian public health system
Oliveira Scarponi, Cristiane Faria
Ferreira Pedrosa, Marco Antonio
Gomes Mol, Marcos Paulo
Mascarenhas Hardman, Michael John
Greco, Dirceu Bartolomeu
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2022, 55
[45] Use of hepatitis B vaccine for the treatment of chronic hepatitis B
Ishikawa, Tetsuya
Kakumu, Shinichi
HEPATOLOGY RESEARCH, 2007, 37 : S347 - S350
[46] Treatment eligibility in hepatitis B: a call for better linkage to optimal care
Huang, Daniel Q.
Nguyen, Mindie H.
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (03): : 160 - 160
[47] Treatment of viral hepatitis (I).: Treatment of chronic hepatitis B
Sanchez-Quijano, Armando
Lissen, Eduardo
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2006, 24 (07): : 453 - 462
[48] Chronic hepatitis C in Latinos:: Natural history, treatment eligibility, acceptance, and outcomes
Cheung, RC
Currie, S
Shen, H
Ho, SB
Bini, EJ
Anand, BS
Bräu, N
Wright, TL
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (10): : 2186 - 2193
[49] aMAP Score and Its Combination With Liver Stiffness Measurement Accurately Assess Liver Fibrosis in Chronic Hepatitis B Patients
Fan, Rong
Li, Guanlin
Yu, Ning
Chang, Xiujuan
Arshad, Tamoore
Liu, Wen-Yue
Chen, Yan
Wong, Grace Lai-Hung
Jiang, Yiyue
Liang, Xieer
Chen, Yongpeng
Jin, Xiao-Zhi
Dong, Zheng
Leung, Howard Ho-Wai
Wang, Xiao-Dong
Zeng, Zhen
Yip, Terry Cheuk-Fung
Xie, Qing
Tan, Deming
You, Shaoli
Ji, Dong
Zhao, Jun
Sanyal, Arun J.
Sun, Jian
Zheng, Ming-Hu
Wong, Vincent Wai-Sun
Yang, Yongping
Hou, Jinlin
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (12) : 3070 - +
[50] The staging score is the major indicator to use either interferon or lamivudine for the treatment of chronic hepatitis B
Shindo, BM
Hamada, K
Nishioji, K
Muramatsu, A
Okuno, T
HEPATOLOGY, 2002, 36 (04) : 632A - 632A

← 1 2 3 4 5 →